ReviewDiabetology & metabolic syndrome2026
Evaluating the therapeutic benefits and safety of ecnoglutide for type 2 diabetes: evidence from a systematic review and meta-analysis.
Saaed Abunada et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.